A new class of treatment approaches for MS being studied are Bruton’s Tyrosine Kinase (BTK) inhibitors, or BTKi. Designed as once-daily oral enzyme inhibitors, BTK inhibitors target specific immune cells…
Read More
Our immune system is a vast and powerful network, filled with specialized cells and proteins designed to protect us from infections and diseases. However, in autoimmune diseases like MS, some…
Research is the driver of progress in MS care and treatment. In this issue, we’ll take you inside some of the most promising innovations transforming the MS landscape. We begin…
The Rocky Mountain MS Center’s 2024 Fall Education Summit was held on Saturday, November 16, 2024, in-person at the Anschutz Medical Campus in Aurora, Colorado, and livestreaming on Zoom. Complete…
Conversations on MS with the Rocky Mountain MS Center Medical Director Dr. Enrique Alvarez, recorded live in Colorado Springs on October 29, 2024. ** PLEASE NOTE: We are aware of…
Open enrollment for healthcare insurance plans under the federal Affordable Care Act is underway beginning November 1. Open enrollment for Colorado marketplace health insurance runs from November 1st through December…
The Rocky Mountain MS Center team is heartbroken to share the loss of our close colleague and friend, Brooke Valdez. Brooke worked as a Program Manager for 12 years at…
Participants in our King Adult Day Enrichment Program (KADEP) choose from dozens of weekly exercise, recreational, educational and social groups and outings to learn new skills and to cultivate an...
Read MoreThe use of stem cell treatments for multiple sclerosis has been increasingly studied. However, while there is only limited data on the effectiveness of these treatments, there are many concerns…
Preparing for his retirement after more than three decades in the field, the MS Center’s Dr. John Corboy reflects on his career and shares his hope for the future of…